林達控股(01041.HK)接獲新增復牌指引 繼續停牌
格隆匯 3 月 5日丨林達控股(01041.HK)公吿, 公司進一步獲聯交所通知以下:
(1)修改要求將針對公司清盤呈請(或清盤令,如有)已被撤回或被解除的復牌指引如下:"針對公司清盤呈請(或清盤令,如有)已被撤回或被解除,並且解除了任何清盤人的任命(無論是否臨時)。"(2)設置以下復牌指引:(a)對事件進行適當的獨立調查,評估對公司業務運營和財務狀況的影響,披露調查結果和影響,並採取適當的補救措施;(b)對酒店挪用事件進行適當的獨立調查,評估對公司業務運營和財務狀況的影響,披露調查結果和影響,並採取適當的補救措施。
聯交所表示,在適當時,它可能會修改復牌指引及提供進一步指引。
繼續暫停買賣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.